Structure and expression of two kininogen genes in mice

Biological Chemistry

Volumn 385, Issue 3-4, 2004, Pages 295-301

  Cardoso, Cibele C ^a   Garrett, Tawana ^a,b   Cayla, Cécile ^a   Meneton, Pierre ^c   Pesquero, João ^d   Bader, Michael ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b ALBANY STATE UNIVERSITY   (United States)

^c INSERM   (France)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alternative splicing; Gene structure; Kallikrein kinin system

Indexed keywords

ISOPROTEIN; KININOGEN; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CHROMOSOME 16; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; KIDNEY PARENCHYMA; LIVER; MALE; MAMMAL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SPLICING;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; GENE EXPRESSION REGULATION; GENE ORDER; KININOGEN, HIGH-MOLECULAR-WEIGHT; KININOGEN, LOW-MOLECULAR-WEIGHT; KININOGENS; MALE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS;

BOS TAURUS; MAMMALIA;

EID: 2542419881     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.025     Document Type: Article

References (27)

1. Baltatu, O., Cayla, C., Iliescu, R., Andreev, D., Jordan, C., and Bader, M. (2002). Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J. Am. Soc. Nephrol. 13, 2681-2687.
2. Bhoola, K. D., Figueroa, C. D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
3. Borkowski, J. A., Ransom, R. W., Seabrook, G. R., Trumbauer, M., Chen, H., Hill, R. G., Strader, C. D., and Hess, J. F. (1995). Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. 270, 13706-13710.
4. Chavakis, T., Santoso, S., Clemetson, K. J., Sachs, U. J., Isordia-Salas, I., Pixley, R. A., Nawroth, P. P., Colman, R. W., and Preissner, K. T. (2003). High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. J. Biol. Chem. 278, 45375-45381
5. Colman, R. W. and Schmaier, A. H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90, 3819-3843.
6. Hu, C.-B., Carretero, O. A., Alhenc-Gelas, F., Meneton, P., and Shesely, E. G. (2001). Discovery of an expressed kininogen-like gene in mice. Hypertension 38, 971, Abstract 52.
7. Joseph, K., Tholanikunnel, B. G., and Kaplan, A. P. (2002). Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc. Natl. Acad. Sci. USA 99, 896-900.
8. Kakizuka, A., Kitamura, N., and Nakanishi, S. (1988). Localization of DNA sequences governing alternative mRNA production of rat kininogen genes. J. Biol. Chem. 263, 3884-3892.
9. Kakizuka, A., Ingi, T., Murai, T, and Nakanishi, S. (1990). A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen genes. J. Biol. Chem. 265, 10102-10108.
10. Kaplan, A. P., Joseph, K., and Silverberg, M. (2002). Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109, 195-209.
11. Kitamura, N., Takagaki, Y., Furuto, S., Tanaka, T., Nawa, H., and Nakanishi, S. (1983). A single gene for bovine high molecular weight and low molecular weight kininogens. Nature 305, 545-548.
12. Kitamura, N., Ohkubo, H., and Nakanishi, S. (1987). Molecular biology of the angiotensinogen and kininogen genes. J. Cardiovasc. Pharmacol. 10 (Suppl. 7), 49-53.
13. Krijanovski, Y., Proulle, V., Mahdi, F., Dreyfus, M., Müller-Esterl, W., and Schmaier, A. H. (2003). Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression. Blood 101, 4430-4436.
14. Marceau, F., Hess, J. F., and Bachvarov, D. R. (1998). The B1 receptors for kinins. Pharmacol. Rev. 50, 357-386.
15. Matheson, R. T., Miller, D. R., Lacombe, M. J., Han, Y. N., Iwanaga, S., Kato, H., and Wuepper, K. D. (1976). Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen. J. Clin. Invest 58, 1395-1406.
16. Meneton, P., Bloch-Faure, M., Hagege, A. A., Ruetten, H., Huang, W., Bergaya, S., Ceiler, D., Gehring, D., Martins, I., Salmon, G. et al. (2001). Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc. Natl. Acad. Sci. USA 98, 2634-2639.
17. Nukaya, M., Takahashi, Y., Gonzalez, F. J., and Kamataki, T. (2001). Aryl hydrocarbon receptor-mediated suppression of expression of the low-molecular-weight prekininogen gene in mice. Biochem. Biophys. Res. Commun. 287, 301-304.
18. Ohkubo, I., Kurachi, K., Takasawa, T., Shiokawa, H., and Sasaki, M. (1984). Isolation of a human cDNA for a2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. Biochemistry 23, 5691-5697.
19. Pesquero, J. B., Lindsey, C. J., Zeh, K., Paiva, A. C. M., Ganten, D., and Bader, M. (1994). Molecular structure and expression of the rat bradykinin B2 receptor gene: evidence for alternative splicing. J. Biol. Chem. 269, 26920-26925.
20. Pesquero, J. B., Araujo, R. C., Heppenstall, P. A., Stucky, C. L., Silva, J. A., Jr., Walther, T., Oliveira, S. M., Pesquero, J. L., Paiva, A. C., Calixto, J. B., Lewin, G. R., and Bader, M. (2000). Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. USA 97, 8140-8145.
21. Raab, A. and Kemme, M. (2000). High-molecular-weight kininogen is a binding protein for tissue prokallikrein. FEBS Lett. 467, 165-168.
22. r kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem. J. 234, 429-434.
23. Shariat-Madar, Z., Mahdi, F., and Schmaier, A. H. (2002). Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277, 17962-17969.
24. Takagaki, Y., Kitamura, N., and Nakanishi, S. (1985). Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. J. Biol. Chem. 260, 8601-8609.
25. Takano, M., Kondo, J., Yayama, K., Otani, M., Sano, K., and Okamoto, H. (1997). Molecular cloning of cDNAs for mouse low-molecular-weight and high-molecular-weight prekininogens. Biochim. Biophys. Acta 1352, 222-230.
26. Werle, E., Götze, W., and Keppler, A. (1937). Über die Wirkung des Kallikreins auf den isolierten Darm und über eine neue darmkontrahierende Substanz. Biochem. Zeitschr. 289, 217-233.
27. Zhao, A., Lew, J. L., Huang, L., Yu, J., Zhang, T., Hrywna, Y., Thompson, J. R., de Pedro, N., Blevins, R. A., Pelaez, F., Wright, S. D., and Cui, J. (2003). Human kininogen gene is transactivated by the farnesoid X receptor. J. Biol. Chem. 278, 28765-28770.